Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).

Oncotarget · 2018 · PMC5915137 · PMID 29707129

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

In addition to that, the results of our study showed an interesting trend toward a not significant increase of cPD-L1 levels according to the number of metastatic sites in the included population.

also in 1,783 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.